Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Option Care Health (OPCH) Net Income (2016 - 2025)

Historic Net Income for Option Care Health (OPCH) over the last 17 years, with Q3 2025 value amounting to $51.8 million.

  • Option Care Health's Net Income fell 387.53% to $51.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $209.2 million, marking a year-over-year increase of 19.25%. This contributed to the annual value of $211.8 million for FY2024, which is 2068.7% down from last year.
  • As of Q3 2025, Option Care Health's Net Income stood at $51.8 million, which was down 387.53% from $50.5 million recorded in Q2 2025.
  • In the past 5 years, Option Care Health's Net Income ranged from a high of $114.4 million in Q2 2023 and a low of -$2.9 million during Q1 2021
  • For the 5-year period, Option Care Health's Net Income averaged around $48.3 million, with its median value being $47.6 million (2022).
  • Per our database at Business Quant, Option Care Health's Net Income soared by 209042.62% in 2021 and then plummeted by 5363.67% in 2024.
  • Quarter analysis of 5 years shows Option Care Health's Net Income stood at $75.5 million in 2021, then crashed by 36.97% to $47.6 million in 2022, then increased by 20.1% to $57.1 million in 2023, then increased by 5.29% to $60.1 million in 2024, then decreased by 13.94% to $51.8 million in 2025.
  • Its Net Income was $51.8 million in Q3 2025, compared to $50.5 million in Q2 2025 and $46.7 million in Q1 2025.